Teva Slaps Lupin With Patent Suit Over Seasonale

Law360, New York (October 8, 2009, 6:13 PM EDT) -- Teva Women’s Health Inc. has filed a patent infringement suit against Lupin Ltd. over its plans to market a generic version of Seasonale, an oral contraceptive that limits the number of menstrual periods women have in a year.

Teva lodged the suit Tuesday in the U.S. District Court for the District of New Jersey, claiming that Lupin had filed an abbreviated new drug application with the U.S. Food and Drug Administration for a generic version of the contraceptive in August.

The patent-in-suit, U.S. Patent Number RE29,861,...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.